Description
The Centers for Disease Control and Prevention (CDC) is seeking to procure Geneious Prime software licenses for 200 users. The contract will be for a firm fixed price and will have a period of performance from February 23, 2026, to February 22, 2028, with one 12-month base period and one 12-month option. The contractor will be required to provide manufacturer-specific subscriptions for Geneious Prime software licenses. The solicitation is brand-name specific, and "equal" products will not be accepted. The CDC will evaluate offers based on technical approach and capability, price, and past performance.
• The contract requires the contractor to provide Geneious Prime software licenses for 200 users.
• The contractor must provide manufacturer-specific subscriptions for Geneious Prime software licenses.
• The contract has a period of performance from February 23, 2026, to February 22, 2028.
• The CDC will evaluate offers based on technical approach and capability, price, and past performance.
• The contractor must comply with Section 508 accessibility standards and provide an Accessibility Conformance Report.
• The contractor must also comply with information security and privacy requirements, including the protection of personally identifiable information (PII) and controlled unclassified information (CUI).